POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Mental Retardation Type B2 Genetic Test
Test Name: POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Mental Retardation Type B2 Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Mental Retardation), Type B2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Mental Retardation), Type B2.
Test Details: The POMT2 gene is associated with a specific type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2. This genetic disorder is characterized by muscle weakness and wasting, intellectual disability, and structural abnormalities in the brain. NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of POMT2 gene-related disorders, NGS genetic testing can identify any variations or mutations in the POMT2 gene that may be causing the disease. NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment planning. It can help confirm the presence of specific genetic mutations, guide appropriate medical management, and provide genetic counseling to affected individuals and their families. It’s important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations.
Test Name | POMT2 Gene Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2 |
Test Details |
The POMT2 gene is associated with a specific type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2. This genetic disorder is characterized by muscle weakness and wasting, intellectual disability, and structural abnormalities in the brain. NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of POMT2 gene-related disorders, NGS genetic testing can identify any variations or mutations in the POMT2 gene that may be causing the disease. NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment planning. It can help confirm the presence of specific genetic mutations, guide appropriate medical management, and provide genetic counseling to affected individuals and their families. It’s important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations. |